Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model

Journal of Infection and Chemotherapy

Volumn 10, Issue 5, 2004, Pages 268-273

  Yoshikawa, Yuka ^a   Morikawa, Keiko ^a   Nonaka, Mitsuko ^a   Torii, Ikuko ^b  

^a SAGAMI WOMEN'S UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Arbekacin; Biofilm; Methicillin resistant Staphylococcus aureus (MRSA)

Indexed keywords

HABEKACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL INFECTION; HISTOCHEMISTRY; INFLAMMATION; MALE; MEMBRANE STRUCTURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORPHOLOGY; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS INFECTION;

EID: 11244334524     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0336-0     Document Type: Article

References (11)

1. Friedrich G. Microreviews Staphylococcus and biofilms. Mol Microbiol 2002;43:1367-78.
2. Yasuda H, Koga T, Fukuda T. In vitro and in vivo models of bacterial biofilms. Methods Enzymol 1999;310:577-84.
3. Wallace JL, Chapman K, Mcknight W. Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenan-air pouch inflammation. Br J Pharmacol 1999;126:1200-4.
4. Brauner E, Gorbach S, Davey P. Comparative study of clindamycin, impenem, oxacillin and vancomycin in the infected granuloma pouch model. J Antimicrob Chemother 1989;23:891-8.
5. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T. Interaction between biofilm formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993;37:1749-55.
6. Ajiki Y, Koga T, Ohya S, Takeuchi T, Yasua H, Watanabe K, et al. β-Lactamase produced by a highly β-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections. J Antimicrob Chemother 1991;28:537-46.
7. Inoue M, Nonoyama M, Okamoto R, Ida T. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphyococcus aureus. Drugs Exp Clin Res 1994;20:233-9.
8. Hayashi I, Inoue M, Hashimoto H. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. Drugs Exp Clin Res 1994;20:225-32.
9. Tanaka N, Matsunaga K, Hirata A, Matsuhisa Y, Nishimura T. Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic. Antimicrob Agents Chemother 1983;24: 797-802.
10. Michael D Jr, Mason EO Jr, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993;37:2522-6.
11. Okai Y, Ishizaka S. A possible immunomodulating activity of arbekacin (ABK), a newly synthesized antibiotic against methicillin-resistant Staphylococcus aureus (MRSA). Int J Immunopharmacol 1994;16:321-7.